FULVESTRANT-HEXAL 250MG/5ML I.M. 2 PREF. SYRINGS

It is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is a complete estrogen receptor antagonist with no agonist effects which in addition accelerates the proteasomal degradation of the estrogen receptor.